Header Logo

Connection

Shlomit Schaal to Bevacizumab

This is a "connection" page, showing publications Shlomit Schaal has written about Bevacizumab.
Connection Strength

2.173
  1. Schaal S, Sherman MP, Nesmith B, Barak Y. UNTREATED OBSTRUCTIVE SLEEP APNEA HINDERS RESPONSE TO BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION. Retina. 2016 Apr; 36(4):791-7.
    View in: PubMed
    Score: 0.507
  2. Ozkok A, Schaal S. Reply: To PMID 25748280. Retina. 2015 Sep; 35(9):e56-7.
    View in: PubMed
    Score: 0.487
  3. Ozkok A, Saleh OA, Sigford DK, Heroman JW, Schaal S. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion. Retina. 2015 Jul; 35(7):1393-400.
    View in: PubMed
    Score: 0.482
  4. Rifkin L, Schaal S. Shortening ocular pain duration following intravitreal injections. Eur J Ophthalmol. 2012 Nov-Dec; 22(6):1008-12.
    View in: PubMed
    Score: 0.386
  5. Jusufbegovic D, Mugavin MO, Schaal S. EVOLUTION OF CONTROLLING DIABETIC RETINOPATHY: Changing Trends in the Management of Diabetic Macular Edema at a Single Institution Over the Past Decade. Retina. 2015 May; 35(5):929-34.
    View in: PubMed
    Score: 0.119
  6. Nesmith BL, Ihnen M, Schaal S. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea. Retina. 2014 Dec; 34(12):2423-30.
    View in: PubMed
    Score: 0.116
  7. Schaal S, Kaplan HJ, Tezel TH. Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology. 2008 Dec; 115(12):2199-205.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.